BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 32587408)

  • 1. Ursodeoxycholic acid improves feto-placental and offspring metabolic outcomes in hypercholanemic pregnancy.
    Borges Manna L; Papacleovoulou G; Flaviani F; Pataia V; Qadri A; Abu-Hayyeh S; McIlvride S; Jansen E; Dixon P; Chambers J; Vazquez-Lopez M; Wahlström A; Kitaba N; Marschall HU; Godfrey KM; Lillycrop K; Williamson C
    Sci Rep; 2020 Jun; 10(1):10361. PubMed ID: 32587408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrahepatic cholestasis of pregnancy: changes in maternal-fetal bile acid balance and improvement by ursodeoxycholic acid.
    Brites D
    Ann Hepatol; 2002; 1(1):20-8. PubMed ID: 15114292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticotropin-releasing hormone expression in patients with intrahepatic cholestasis of pregnancy after ursodeoxycholic acid treatment: an initial experience.
    Zhou F; Zhang L; He MM; Liu ZF; Gao BX; Wang XD
    Curr Med Res Opin; 2014 Aug; 30(8):1529-35. PubMed ID: 24665980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of ursodeoxycholic acid treatment on the altered progesterone and bile acid homeostasis in the mother-placenta-foetus trio during cholestasis of pregnancy.
    Estiú MC; Monte MJ; Rivas L; Moirón M; Gomez-Rodriguez L; Rodriguez-Bravo T; Marin JJ; Macias RI
    Br J Clin Pharmacol; 2015 Feb; 79(2):316-29. PubMed ID: 25099365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The reversed feto-maternal bile acid gradient in intrahepatic cholestasis of pregnancy is corrected by ursodeoxycholic acid.
    Geenes V; Lövgren-Sandblom A; Benthin L; Lawrance D; Chambers J; Gurung V; Thornton J; Chappell L; Khan E; Dixon P; Marschall HU; Williamson C
    PLoS One; 2014; 9(1):e83828. PubMed ID: 24421907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bile acids evoke placental inflammation by activating Gpbar1/NF-κB pathway in intrahepatic cholestasis of pregnancy.
    Zhang Y; Pan Y; Lin C; Zheng Y; Sun H; Zhang H; Wang J; Yuan M; Duan T; Du Q; Chen J
    J Mol Cell Biol; 2016 Dec; 8(6):530-541. PubMed ID: 27402811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A placental phenotype for intrahepatic cholestasis of pregnancy.
    Geenes VL; Lim YH; Bowman N; Tailor H; Dixon PH; Chambers J; Brown L; Wyatt-Ashmead J; Bhakoo K; Williamson C
    Placenta; 2011 Dec; 32(12):1026-32. PubMed ID: 22015023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fetal cardiac dysfunction in intrahepatic cholestasis of pregnancy is associated with elevated serum bile acid concentrations.
    Vasavan T; Deepak S; Jayawardane IA; Lucchini M; Martin C; Geenes V; Yang J; Lövgren-Sandblom A; Seed PT; Chambers J; Stone S; Kurlak L; Dixon PH; Marschall HU; Gorelik J; Chappell L; Loughna P; Thornton J; Pipkin FB; Hayes-Gill B; Fifer WP; Williamson C
    J Hepatol; 2021 May; 74(5):1087-1096. PubMed ID: 33276032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bile acid patterns in meconium are influenced by cholestasis of pregnancy and not altered by ursodeoxycholic acid treatment.
    Rodrigues CM; Marín JJ; Brites D
    Gut; 1999 Sep; 45(3):446-52. PubMed ID: 10446117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obeticholic acid improves fetal bile acid profile in a mouse model of gestational hypercholanemia.
    Pataia V; McIlvride S; Papacleovoulou G; Ovadia C; McDonald JAK; Wahlström A; Jansen E; Adorini L; Shapiro D; Marchesi JR; Marschall HU; Williamson C
    Am J Physiol Gastrointest Liver Physiol; 2020 Aug; 319(2):G197-G211. PubMed ID: 32597707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrahepatic cholestasis of pregnancy: a randomized controlled trial comparing dexamethasone and ursodeoxycholic acid.
    Glantz A; Marschall HU; Lammert F; Mattsson LA
    Hepatology; 2005 Dec; 42(6):1399-405. PubMed ID: 16317669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the effectiveness and safety of ursodeoxycholic acid in treatment of intrahepatic cholestasis of pregnancy: A meta-analysis (a prisma-compliant study).
    Kong X; Kong Y; Zhang F; Wang T; Yan J
    Medicine (Baltimore); 2016 Oct; 95(40):e4949. PubMed ID: 27749550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of ursodeoxycholic acid treatment for intrahepatic cholestasis of pregnancy on maternal and fetal outcomes: a meta-analysis including non-randomized studies.
    Grand'Maison S; Durand M; Mahone M
    J Obstet Gynaecol Can; 2014 Jul; 36(7):632-641. PubMed ID: 25184983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal cholestasis during pregnancy programs metabolic disease in offspring.
    Papacleovoulou G; Abu-Hayyeh S; Nikolopoulou E; Briz O; Owen BM; Nikolova V; Ovadia C; Huang X; Vaarasmaki M; Baumann M; Jansen E; Albrecht C; Jarvelin MR; Marin JJ; Knisely AS; Williamson C
    J Clin Invest; 2013 Jul; 123(7):3172-81. PubMed ID: 23934127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bile acid stress in the mother and baby unit.
    Howard PJ; Murphy GM
    Eur J Gastroenterol Hepatol; 2003 Mar; 15(3):317-21. PubMed ID: 12610328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial effect of ursodeoxycholic acid on alterations induced by cholestasis of pregnancy in bile acid transport across the human placenta.
    Serrano MA; Brites D; Larena MG; Monte MJ; Bravo MP; Oliveira N; Marin JJ
    J Hepatol; 1998 May; 28(5):829-39. PubMed ID: 9625319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ursodeoxycholic acid versus placebo in the treatment of women with intrahepatic cholestasis of pregnancy (ICP) to improve perinatal outcomes: protocol for a randomised controlled trial (PITCHES).
    Chappell LC; Chambers J; Dixon PH; Dorling J; Hunter R; Bell JL; Bowler U; Hardy P; Juszczak E; Linsell L; Rounding C; Smith A; Williamson C; Thornton JG
    Trials; 2018 Nov; 19(1):657. PubMed ID: 30482254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of sphingolipids in the pathogenesis of intrahepatic cholestasis.
    Mikucka-Niczyporuk A; Pierzynski P; Lemancewicz A; Kosinski P; Charkiewicz K; Knas M; Kacerovsky M; Blachnio-Zabielska A; Laudanski P
    Prostaglandins Other Lipid Mediat; 2020 Apr; 147():106399. PubMed ID: 31733339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzymatic quantification of total serum bile acids as a monitoring strategy for women with intrahepatic cholestasis of pregnancy receiving ursodeoxycholic acid treatment: a cohort study.
    Manna LB; Ovadia C; Lövgren-Sandblom A; Chambers J; Begum S; Seed P; Walker I; Chappell LC; Marschall HU; Williamson C
    BJOG; 2019 Dec; 126(13):1633-1640. PubMed ID: 31483939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pregnancy course in patients with intrahepatic cholestasis of pregnancy treated with very low doses of ursodeoxycholic acid.
    Grymowicz M; Czajkowski K; Smolarczyk R
    Scand J Gastroenterol; 2016 Jan; 51(1):78-85. PubMed ID: 26152830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.